文献速递冠心病外科

冠状动脉旁路移植术后双联抗血小板治疗的模式与预测因素

Pattern and predictors of dual antiplatelet use after coronary artery bypass graft surgery.
PubMed 文献 · J Thorac Cardiovasc Surg · 2017-09-28

该单中心回顾性研究纳入2014至2016年572例因急性冠脉综合征行冠状动脉旁路移植术的患者,发现仅29%出院时使用双联抗血小板治疗。校正术者偏好后,年龄增加和出院带抗凝药与双联抗血小板治疗使用几率降低相关,非体外循环冠状动脉旁路移植术与使用几率增加相关。

要点

  • 急性冠脉综合征行冠状动脉旁路移植术后双联抗血小板治疗出院率仅29%。
  • 年龄增加和出院带抗凝药与双联抗血小板治疗使用几率降低相关。
  • 非体外循环冠状动脉旁路移植术与双联抗血小板治疗使用几率增加相关。

核心结论

  • 急性冠脉综合征行冠状动脉旁路移植术患者双联抗血小板治疗使用率低且术者间存在差异。
  • 双联抗血小板治疗使用与否受既往缺血和出血风险因素及术者偏好影响。

研究设计与样本

  • 单中心回顾性研究,纳入2014至2016年因急性冠脉综合征行冠状动脉旁路移植术的患者572例。
  • 采用混合效应多变量逻辑回归评估双联抗血小板治疗使用的预测因素,并校正术者特异性偏好。
  • 使用受试者工作特征分析评估模型区分能力。

主要发现

  • 572例患者中仅29%出院时使用双联抗血小板治疗。
  • 预测模型的C指数为0.74。

临床怎么用

  • 临床应关注急性冠脉综合征行冠状动脉旁路移植术患者出院时双联抗血小板治疗的使用情况。
  • 术者偏好可能影响双联抗血小板治疗决策,需结合缺血和出血风险个体化评估。

局限性

  • 单中心回顾性研究,结果可能受中心实践模式影响。
  • 样本量有限,结论需多中心研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Resumption of dual antiplatelet therapy after coronary artery bypass grafting in patients presenting with acute coronary syndrome is recommended, but the current practice pattern in the United States remains unknown. We aimed to investigate the current pattern of dual antiplatelet therapy use after coronary artery bypass grafting at the Yale-New Haven Hospital. METHODS: We conducted a single-center retrospective review of patients who presented with acute coronary syndrome and underwent coronary artery bypass grafting between 2014 and 2016. The primary outcome was hospital discharge with dual antiplatelet therapy. Mixed-effect multivariate logistic regression was used to evaluate predictors of dual antiplatelet therapy use or nonuse, accounting for surgeon-specific preference. The discriminatory ability of the model was evaluated with receiver operating characteristics analysis. RESULTS: Of 572 patients included, only 29% were discharged with dual antiplatelet therapy. In the mixed-effect multivariate model isolating surgeon preferences, increase in age (odds ratio, 0.95; 95% confidence interval, 0.92-0.98; P < .001) and discharge with anticoagulants (odds ratio, 0.20; 95% confidence interval, 0.07-0.55; P = .002) were associated with lower odds of dual antiplatelet therapy use. Off-pump coronary artery bypass grafting compared with on-pump coronary artery bypass grafting was associated with increased odds of dual antiplatelet therapy use (odds ratio, 31.5; 95% confidence interval, 12.8-77.2; P < .001). C-index of the prediction model was 0.74. CONCLUSIONS: The overall rate of dual antiplatelet therapy use in patients with acute coronary syndrome who underwent coronary artery bypass grafting was low and variable among surgeons. The use or nonuse was guided by previously established risk factors of recurrent ischemia and bleeding, along with surgeon preference.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Mori M, Shioda K, Yun JJ, et al. Pattern and predictors of dual antiplatelet use after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg. 2017. PMID: 29056263. doi:10.1016/j.jtcvs.2017.09.092

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。